Press Releases | Investor Relations

Dec 24 2013
AmpliPhi Biosciences Closes $18 Million Private Placement
Dec 16 2013
AmpliPhi Biosciences Announces $18 Million Private Placement
Nov 13 2013
AmpliPhi Biosciences Announces the Appointment of Baxter Phillips, III, as Vice President of Corporate Strategy and Business Development
Oct 16 2013
AmpliPhi Signs Exclusive License With University of Leicester, UK to Develop Bacteriophage Therapies Targeting C. Difficile
Aug 08 2013
AmpliPhi Presents Data on Bacteriophages in the Treatment of Lung Infections in Cystic Fibrosis
Jul 01 2013
AmpliPhi Signs Global R&D Agreement with US Army to Develop Bacteriophage Therapies to Treat Resistant Bacterial Infections
Jun 27 2013
AmpliPhi Closes $7 Million Private Placement
Apr 16 2013
AmpliPhi Establishes Collaboration with Intrexon
Feb 04 2013
AmpliPhi Receives Notice of Allowance on Key Patent for its Bacteriophage Therapy to Treat Drug-resistant Biofilm-based Infections